The Uncertain Path Forward for Psychedelic Medicine

After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its founder has left the company…
Read More

About Author

Emily Mullin

See author's posts

The Uncertain Path Forward for Psychedelic Medicine

About Author

Emily Mullin

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

No QoL Downside With Adding Nivo to Chemo in Urothelial Cancer

E-cigarette Use May Alter Healthy Nasal Mucosa

Oncologica to advance urine-based prostate cancer screening test

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

FDA Approves Benralizumab for EGPA Vasculitis Indication

Study finds early puberty linked to higher risk for HS

CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated

Summer COVID surge isn’t cause for alarm, experts say

Budget FY25: Pharmaceuticals sector needs a major boost with increased focus on R&D and innovation

Dental veneers: Everything you need to know

Cheeky diet soft drink getting you through the work day? Here’s what that may mean for your health

UK teenagers get two-thirds of their calories from ultra-processed foods—new study

Oncologica to advance urine-based prostate cancer screening test

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

FDA Approves Benralizumab for EGPA Vasculitis Indication

Study finds early puberty linked to higher risk for HS

CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories